Single-dose pharmacokinetics of daptomycin in pediatric patients 3-24 months of age.
about
Development of Human Membrane Transporters: Drug Disposition and PharmacogeneticsClinical Effectiveness, Safety Profile, and Pharmacokinetics of Daptomycin in Pediatric Patients: A Systematic Review.Clinical Experience with Daptomycin in Pediatrics.The Use of Daptomycin to Treat Methicillin-Resistant Staphylococcus Epidermidis Bacteremia in a Critically Ill Child with Renal Failure.
P2860
Single-dose pharmacokinetics of daptomycin in pediatric patients 3-24 months of age.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Single-dose pharmacokinetics of daptomycin in pediatric patients 3-24 months of age.
@en
type
label
Single-dose pharmacokinetics of daptomycin in pediatric patients 3-24 months of age.
@en
prefLabel
Single-dose pharmacokinetics of daptomycin in pediatric patients 3-24 months of age.
@en
P2093
P1476
Single-dose pharmacokinetics of daptomycin in pediatric patients 3-24 months of age.
@en
P2093
David Benziger
John S Bradley
Paula Bokesch
Richard Jacobs
P304
P356
10.1097/INF.0000000000000318
P577
2014-09-01T00:00:00Z